Archived Seminar: Parkinson's Disease and Why Development Matters
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
Parkinson’s Disease (PD) is defined clinically by motor symptoms that usually arise late in life and are the result of the loss of dopaminergic neurons, but a variety of nonmotor symptom including depression can precede these symptoms by many years, and genes causing PD are normally expressed throughout the lifespan, including development. It is with this in mind, that we have been examining the effect of PD-causing gene mutations on brain development. Our data show that a knockin mutation of the most prevalent genetic cause of PD, LRRK2-G2019S, alters the structure and function of corticostriatal circuits, and suggest that LRRK2-G2019S coopts synaptic circuits early in life, biasing the actions of cellular pathways in ways that have enduring consequences for learning and stress-related responses in young adulthood. The changes we observe serve to outline novel pathways that can be used to understand, detect, or treat PD.
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Neurobiology Research and the Center for Glial Biology in Health, Disease, and Cancer. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
General ItemVirtual Public Lecture: How Vaccines Train the Immune System in Ways No One Expected
April 15, 2021, 5:30 p.m. | Christine Stabell Benn, M.D., Ph.D., D.M.Sc. | Maury Strauss Distinguished Public Lecture
General ItemVirtual Seminar: Aerobic Fitness and Susceptibility for Metabolic Dysfunction
April 16, 2021, 11 a.m. | John Thyfault, Ph.D. | Pioneers in Biomedical Research Seminar Series
General ItemVirtual Lecture: Mechanism of Treatment Resistance in Human Glioblastoma
April 16, 2021, 1 p.m. | W.K. Alfred Yung, M.D. | Timothy A. Johnson Medical Scholar Seminar Series
General ItemVirtual Seminar: Multi-channel MEG Measurements with a Wearable OPM System
April 23, 2021, 11 a.m. | Elena Boto, Ph.D. | Pioneers in Biomedical Research Seminar Series
General ItemVirtual Seminar: Control of TGF-beta Signaling and Epithelial-Mesenchymal Transition
April 30, 2021, 11 a.m. | Rik Derynck, Ph.D. | Pioneers in Biomedical Research Seminar Series
Deanna Benson, Ph.D.
Professor in the Nash Family Department of Neuroscience and the Friedman Brain Institute at the Icahn School of Medicine at Mount Sinai